206 related articles for article (PubMed ID: 24772329)
21. Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors.
Vyas VK; Ghate M
Mini Rev Med Chem; 2011 Oct; 11(12):1039-55. PubMed ID: 21861807
[TBL] [Abstract][Full Text] [Related]
22. Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides.
Löffler M; Jöckel J; Schuster G; Becker C
Mol Cell Biochem; 1997 Sep; 174(1-2):125-9. PubMed ID: 9309676
[TBL] [Abstract][Full Text] [Related]
23. Functional expression of human dihydroorotate dehydrogenase (DHODH) in pyr4 mutants of ustilago maydis allows target validation of DHODH inhibitors in vivo.
Zameitat E; Freymark G; Dietz CD; Löffler M; Bölker M
Appl Environ Microbiol; 2007 May; 73(10):3371-9. PubMed ID: 17369345
[TBL] [Abstract][Full Text] [Related]
24. Preparation of human dihydroorotate dehydrogenase for interaction studies with lipid bilayers.
Rodriguez JMO; Krupinska E; Wacklin-Knecht H; Knecht W
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1306-1319. PubMed ID: 31997699
[TBL] [Abstract][Full Text] [Related]
25. The target site of the novel fungicide quinofumelin,
Higashimura N; Hamada A; Ohara T; Sakurai S; Ito H; Banba S
J Pestic Sci; 2022 Nov; 47(4):190-196. PubMed ID: 36514691
[TBL] [Abstract][Full Text] [Related]
26. The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia.
Gaidano V; Houshmand M; Vitale N; Carrà G; Morotti A; Tenace V; Rapelli S; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Cilloni D; Cignetti A; Saglio G; Circosta P
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33670894
[TBL] [Abstract][Full Text] [Related]
27. Defects in vesicle core induced by escherichia coli dihydroorotate dehydrogenase.
Couto SG; Nonato MC; Costa-Filho AJ
Biophys J; 2008 Mar; 94(5):1746-53. PubMed ID: 17993483
[TBL] [Abstract][Full Text] [Related]
28. Dihydroorotate dehydrogenase inhibition acts synergistically with tyrosine kinase inhibitors to induce apoptosis of mantle cell lymphoma cells.
Eriksen-Gjerstad M; Tveit Karlsen I; Fandalyuk Z; Benjaminsen S; Baran-Marszak F; Papp B; Locke F; Ladds M; Pastor-Fernández A; Gelebart P; Mc Cormack E
EJHaem; 2022 Aug; 3(3):913-918. PubMed ID: 36051066
[TBL] [Abstract][Full Text] [Related]
29. Dihydroorotate dehydrogenase regulates ferroptosis in neurons after spinal cord injury via the P53-ALOX15 signaling pathway.
Li D; Lu X; Xu G; Liu S; Gong Z; Lu F; Xia X; Jiang J; Wang H; Zou F; Ma X
CNS Neurosci Ther; 2023 Jul; 29(7):1923-1939. PubMed ID: 36942513
[TBL] [Abstract][Full Text] [Related]
30. Protein-lipid interactions of human dihydroorotate dehydrogenase and three mutants associated with Miller syndrome.
Orozco Rodriguez JM; Wacklin-Knecht H; Knecht W
Nucleosides Nucleotides Nucleic Acids; 2022; 41(12):1337-1358. PubMed ID: 35184687
[TBL] [Abstract][Full Text] [Related]
31. Dihydroorotate dehydrogenase promotes cell proliferation and suppresses cell death in esophageal squamous cell carcinoma and colorectal carcinoma.
Shi ZZ; Jin X; Li WT; Tao H; Song SJ; Fan ZW; Jiang W; Liang JW; Bai J
Transl Cancer Res; 2023 Sep; 12(9):2294-2307. PubMed ID: 37859742
[TBL] [Abstract][Full Text] [Related]
32. Retinoblastoma vulnerability to combined
Mollick T; Darekar S; Dalarun B; Plastino F; Zhang J; Fernández AP; Alkasalias T; André H; Laín S
Heliyon; 2024 Jan; 10(1):e23831. PubMed ID: 38332874
[TBL] [Abstract][Full Text] [Related]
33. Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine.
Garcia RA; Liu L; Hu Z; Gonzalez A; von Borstel RW; Saydoff JA
Brain Res; 2005 Dec; 1066(1-2):164-71. PubMed ID: 16330000
[TBL] [Abstract][Full Text] [Related]
34. Indirect inhibition of mitochondrial dihydroorotate dehydrogenase activity by nitric oxide.
Beuneu C; Auger R; Löffler M; Guissani A; Lemaire G; Lepoivre M
Free Radic Biol Med; 2000 Apr; 28(8):1206-13. PubMed ID: 10889450
[TBL] [Abstract][Full Text] [Related]
35. Miller (Genee-Wiedemann) syndrome represents a clinically and biochemically distinct subgroup of postaxial acrofacial dysostosis associated with partial deficiency of DHODH.
Rainger J; Bengani H; Campbell L; Anderson E; Sokhi K; Lam W; Riess A; Ansari M; Smithson S; Lees M; Mercer C; McKenzie K; Lengfeld T; Gener Querol B; Branney P; McKay S; Morrison H; Medina B; Robertson M; Kohlhase J; Gordon C; Kirk J; Wieczorek D; Fitzpatrick DR
Hum Mol Genet; 2012 Sep; 21(18):3969-83. PubMed ID: 22692683
[TBL] [Abstract][Full Text] [Related]
36. Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations.
Malla B; Cotten S; Ulshoefer R; Paul F; Hauser AE; Niesner R; Bros H; Infante-Duarte C
Ther Adv Chronic Dis; 2020; 11():2040622320944773. PubMed ID: 32850106
[TBL] [Abstract][Full Text] [Related]
37. Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase.
Rawls J; Knecht W; Diekert K; Lill R; Löffler M
Eur J Biochem; 2000 Apr; 267(7):2079-87. PubMed ID: 10727948
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells.
Bajzikova M; Kovarova J; Coelho AR; Boukalova S; Oh S; Rohlenova K; Svec D; Hubackova S; Endaya B; Judasova K; Bezawork-Geleta A; Kluckova K; Chatre L; Zobalova R; Novakova A; Vanova K; Ezrova Z; Maghzal GJ; Magalhaes Novais S; Olsinova M; Krobova L; An YJ; Davidova E; Nahacka Z; Sobol M; Cunha-Oliveira T; Sandoval-Acuña C; Strnad H; Zhang T; Huynh T; Serafim TL; Hozak P; Sardao VA; Koopman WJH; Ricchetti M; Oliveira PJ; Kolar F; Kubista M; Truksa J; Dvorakova-Hortova K; Pacak K; Gurlich R; Stocker R; Zhou Y; Berridge MV; Park S; Dong L; Rohlena J; Neuzil J
Cell Metab; 2019 Feb; 29(2):399-416.e10. PubMed ID: 30449682
[TBL] [Abstract][Full Text] [Related]
39. Protein instability and functional defects caused by mutations of dihydro-orotate dehydrogenase in Miller syndrome patients.
Fang J; Uchiumi T; Yagi M; Matsumoto S; Amamoto R; Saito T; Takazaki S; Kanki T; Yamaza H; Nonaka K; Kang D
Biosci Rep; 2012 Dec; 32(6):631-9. PubMed ID: 22967083
[TBL] [Abstract][Full Text] [Related]
40. Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome.
Orozco Rodriguez JM; Krupinska E; Wacklin-Knecht H; Knecht W
Nucleosides Nucleotides Nucleic Acids; 2022; 41(12):1318-1336. PubMed ID: 35094635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
